Kinetic and molecular evidences that human cardiac muscle express non-M2 muscarinic receptor subtypes that are able to interact themselves

Pharmacological Research

Volumn 54, Issue 5, 2006, Pages 345-355

  Pérez, Carmen Carlota Nello ^a   Tobar, Iván Darío Bravo ^a   Jiménez, Eliézer ^a   Castañeda, Darwin ^a   Rivero, Maria Belén ^a   Concepción, Juan Luís ^b   Chiurillo, Miguel Ángel ^a   Bonfante Cabarcas, Rafael ^a  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^b FACULTAD DE CIENCIAS   (Venezuela)

Author keywords

3H QNB binding kinetics; Cooperative interactions; Human heart; Muscarinic receptor subtypes; RT PCR

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; BIPERIDEN; CARBACHOL; METHOCTRAMINE; MUSCARINIC M2 RECEPTOR; PIRENZEPINE; PROTEIN; PROTEIN M1; PROTEIN M2; PROTEIN M3; PROTEIN M4; PROTEIN M5; TROPICAMIDE; UNCLASSIFIED DRUG;

ADULT; ALLOSTERISM; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ATRIUM; HEART MUSCLE; HEART VENTRICLE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; KINETICS; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BINDING, COMPETITIVE; GENE EXPRESSION REGULATION; HEART ATRIA; HEART VENTRICLES; HUMANS; MALE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; MYOCARDIUM; RADIOLIGAND ASSAY; RECEPTORS, MUSCARINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33750152349     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.07.001     Document Type: Article

References (36)

1. Caulfield M.P., and Birdsall N.J.M. International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptor. Pharmacol Rev 50 (1998) 279-290
2. Brodde O.-E., and Michel M.C. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51 (1999) 651-690
3. Gallo M.P., Alloatti G., Eva C., Oberto A., and Levi R.C. M1 muscarinic receptor increase calcium current and phosphoinositide turnover in guinea-pig ventricular cardiocytes. J Physiol (Lond) 471 (1993) 41-60
4. Sharma V.K., Colecraft H.M., Wang D.X., Levey A.I., Grigorenko E.V., Yeh H.H., et al. Molecular and functional identification of m1 muscarinic acetylcholine receptors in ventricular myocites. Circ Res 79 (1996) 86-93
5. Colecraft H.M., Egamino J.P., Sharma V.K., and Sheu S.-S. Signaling mechanism underlying muscarinic receptor-mediated increase in contraction rate in cultured heart cells. J Biol Chem 273 (1998) 32158-32166
6. Gadbut A.P., and Galper J.B. A novel M3 muscarinic acetylcholine receptor is expressed in chick atrium and ventricle. J Biol Chem 269 (1994) 25823-25829
7. McKinnon L.A., and Nathanson N.M. Tissue-specific regulation of muscarinic acetylcholine receptor expressed during embrionic development. J Biol Chem 270 (1995) 20636-20642
8. Fermini B., and Nattel S. Choline chloride activates time-dependant and time-independent K+ current in dog atrial myocites. Am J Phisiol 266 (1994) C42-C51
9. Navarro-Polanco R.A., and Sanchez-Chapula J.A. 4-Aminopyridine activates potassium currents by activation of muscarinic receptor in feline atrial myocites. J Phisiol (Lond) 498 (1997) 663-678
10. Shi H., Wang H., and Wang Z. Identification and characterization of multiple subtypes of muscarinic acetylcholine receptors and their physiological functions in canine hearts. Mol Pharmacol 55 (1999) 497-507
11. Du X.Y., Schomaker R.G., Bos E., and Saxena P.R. Characterization of the positive and negative inotropic effects of acetylcholine in the human myocardium. Eur J Pharmacol 284 (1995) 119-127
12. Meyer E.C., and De Sommers K. Possible mechanisms of anti-cholinergic drug-induced bradycardia. Eur J Clin Pharmacol 35 (1988) 503-506
13. Pitschner H.F., and Wellstein A. Dose-response curves of pirenzepine in man in relation to M1- and M2-cholinoceptor occupancy. Naunyn-Schmiedeberg's Arch Pharmacol 338 (1988) 207-210
14. Giessler C., Dhein S., Pönicke K., and Brodde O.-E. Age-dependent decrease in the negative inotropic effect of carbachol on isolated human right atrium. Eur J Pharmacol 357 (1998) 199-202
15. Wang H., Han H., Zhang L., Shi H., Schram G., Nattel S., et al. Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart. Mol Pharmacol 59 (2001) 1029-1036
16. Smith P.K., Krohn R.L., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
17. Wang J., Krysiak P.S., Laurier L.G., Sims S.M., and Preiksaitis H.G. Human esophageal smooth muscle cells express muscarinic receptor subtypes M(1)through M(5). Am J Physiol Gastrointest Liver Physiol 279 (2000) G1059-G1069
18. Hellgren I., Mustafa A., Riazi M., Suliman I., Sylven C., and Adem A. Muscarinic M3 receptor subtype gene expression in the human heart. Cell Mol Life Sci 20 57 (2000) 175-180
19. Eltze M., and Figala V. Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes. Eur J Pharmacol 158 (1988) 11-19
20. Oberhauser V., Schwertfeger E., Rutz T., Beyersdorf F., and Rump L.C. Acetylcholine release in human heart atrium: influence of muscarinic autoreceptors, diabetes, and age. Circulation 103 (2001) 1638-1643
21. Willmy-Matthes P., Leineweber K., Wangemann T., Silber R.E., and Brodde O.E. Existence of functional M3-muscarinic receptors in the human heart. Naunyn Schmiedebergs Arch Pharmacol 368 (2003) 316-319
22. Ponicke K., Heinroth-Hoffmann I., and Brodde O.E. Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats. Br J Pharmacol 138 (2003) 156-160
23. Hirschberg B., and Schimerlik M. A kinetic model for oxotremorine M binding to recombinant porcine m2 muscarinic receptors expressed in Chinese hamster ovary cells. J Biol Chem 269 (1994) 26127-26135
24. Wreggett K.A., and Wells J.G. Cooperativity manifest in the binding of purified cardiac muscarinic receptors. J Biol Chem 270 (1995) 22488-22499
25. Moreno-Yanez J.A., Pascuzzo-Lima C., and Bonfante-Cabarcas R.A. Inducción de cooperatividad homotrópica positiva en la unión de antagonistas al receptor colinérgico muscarínico de corteza frontal humana. Ciencia 3 (1995) 207-228
26. Tucek S., and Proska J. Allosteric modulation of muscarinic acethylcholine receptors. TiPS 16 (1995) 205-212
27. Chidiac P., Grenn M.A., Pawagi A.B., and Wells J.W. Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity. Biochemistry 36 24 (1997) 7361-7379
28. Potter L.T., Ballesteros A., Bichajian L.H., Ferrendelli C.A., Fisher A., Hanchet H.E., et al. Evidence for paired M2 muscarinic receptors. Mol Pharmacol 39 (1990) 211-221
29. Zeng F.Y., and Wess J. Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem 274 27 (1999) 19487-19497
30. Jarv J., Hedlund B., and Bartfai F. Isomerization of the muscarinic receptor antagonist complex. J Biol Chem 254 (1979) 5595-5598
31. Lee N.H., and el-Fakahany E.E. Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol 42 (1991) 199-205
32. Lanzafane A., Christopoulos A., and Mitchelson F. Three allosteric modulators act at common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors. J Pharmacol Exp Ther 282 (1997) 278-285
33. Kenakin T., and Boselli C. Pharmacological discrimination between receptor heterogeneity and allosteric interactions: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea. Pharmacol Exp Ther 250 (1989) 944-952
34. Waelbroeck M., Camus J., Tastenoy M., and Christphe J. Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptors subtypes. Br J Pharmacol 105 (1992) 97-102
35. Ellis J., and Seidenberg M. Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol Pharmacol 42 (1992) 638-641
36. Novi F., Scarselli M., Corsini G.U., and Maggio R. The paired activation of the two components of the muscarinic M3 receptor dimer is required for induction of ERK 1/2 phosphorylation. J Biol Chem 279 (2004) 7476-7486